is semaglutide wegovy Wegovy® - Tablet Wegovy (semaglutide) Weight Loss Injection

They are contraindicated in patients with a personal or family history of MTC

Results also show that more than 4 in 5 (81%) of patients were prescribed a low maintenance dose of their GLP-1 drug, and that made a difference as well

providers review medical history and vital data before prescribing

A Maahs DM, et al

Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant

That said, oral GLP-1 medications for weight loss are advancing quickly, and the research has become much more compelling this year with newer options scheduled to come on the market soon